- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Guideline for management of sepsis and septic shock: Surviving sepsis campaign - Page 2
De-escalation of antibiotics
- For adults with sepsis or septic shock, the authors suggest daily assessment for de-escalation of antimicrobials over using fixed durations of therapy without daily reassessment for de-escalation.
Duration of antibiotics
- For adults with an initial diagnosis of sepsis or septic shock and adequate source control, the authors suggest using a shorter over a longer duration of antimicrobial therapy.
Biomarkers to discontinue antibiotics
- For adults with an initial diagnosis of sepsis or septic shock and adequate source control where the optimal duration of therapy is unclear, the authors suggest using procalcitonin AND clinical evaluation to decide when to discontinue antimicrobials over clinical evaluation alone.
Fluid management
- For adults with sepsis or septic shock, the authors recommend using crystalloids as first-line fluid for resuscitation.
- For adults with sepsis or septic shock, the authors suggest using balanced crystalloids instead of normal saline for resuscitation.
- For adults with sepsis or septic shock, the authors suggest using albumin in patients who received large volumes of crystalloids over using crystalloids alone.
- For adults with sepsis or septic shock, the authors recommend against using starches for resuscitation.
- For adults with sepsis and septic shock, the authors suggest against using gelatin for resuscitation.
Vasoactive agents
- For adults with septic shock, the authors recommend using norepinephrine as the first-line agent over other vasopressors.
- For adults with septic shock on norepinephrine with inadequate MAP levels, the authors suggest adding vasopressin instead of escalating the dose of norepinephrine.
- For adults with septic shock and inadequate MAP levels despite norepinephrine and vasopressin, the authors suggest adding epinephrine.
- For adults with septic shock, the authors suggest against using terlipressin
Reference:
Evans, L., Rhodes, A., Alhazzani, W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med (2021). https://doi.org/10.1007/s00134-021-06506-y
Source : Intensive Care Medicine
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751